Teladoc Health, Inc. is a telehealth company that provides virtual healthcare services, including medical consultations, mental health support, and chronic condition management. Its core offerings encompass a range of telemedicine solutions, leveraging technology to connect patients with healthcare professionals. Major business segments include primary care, mental health, and specialty care services. The company generates revenue primarily through subscription fees and per-visit charges for its telehealth services.
The investment profile of Teladoc suggests it may be more aligned with growth investors, given its focus on expanding telehealth services in a rapidly evolving market. However, the current financial metrics indicate challenges, which may deter those seeking stable dividends or value opportunities. Investors should consider the potential for recovery against the backdrop of elevated risk factors.
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-07-29 | Hold | Sell | Weak fundamentals and high risk limit upside potential. |
| 2026-07-21 | Sell | Hold | Weak fundamentals with improving momentum; cautious outlook. |
| 2026-07-12 | Hold | Sell | Weak fundamentals and high risk limit upside potential. |
| 2026-07-05 | Sell | Hold | Weak fundamentals and high risk limit upside potential. |
| 2026-06-27 | Hold | Sell | Weak fundamentals and high risk limit upside potential. |
| 2026-06-19 | Sell | Hold | Weak fundamentals and high risk limit upside potential. |
| 2026-06-09 | Hold | Sell | Weak fundamentals and negative momentum signal high risk. |
| 2026-06-01 | Sell | Hold | Weak fundamentals and high risk limit upside potential. |
| 2026-05-08 | — | Sell | Weak fundamentals and high risk limit upside potential. |
| 2026-05-08 | Sell | Sell | Компания Teladoc демонстрирует сильные колебания цен в краткосрочной перспективе, но негативные показатели EPS и снижение выручки указывают на высокие риски. Рекомендуется удерживать акции до получения более стабильных ф |
| 2026-03-11 | — | Sell | Компания Teladoc демонстрирует значительное снижение стоимости акций за последние 60 и 120 дней, что указывает на высокие риски. Отсутствие данных по EPS и выручке также затрудняет оценку её финансового состояния. |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-07-30 | Jefferies | Target Lowered | 9 → 8 | 6.719 |
| 2026-07-30 | Evercore ISI | Target Lowered | 10 → 7.5 | 6.715 |
| 2026-07-21 | Canaccord Genuity | Target Raised | 10 → 11 | 9.65 |
| 2026-04-08 | Evercore ISI | Target Raised | 5 → 6 | 5.27 |
| 2026-03-10 | Deutsche Bank | Update | — → 11 | 5.575 |
| 2026-02-26 | Stifel Nicolaus | Target Lowered | — → 6 | 5.07 |
| 2026-02-26 | Wells Fargo | Target Lowered | — → 6 | 4.65 |
| 2026-01-16 | Goldman Sachs | Target Lowered | 9 → 8 | 6.53 |
| 2026-01-09 | Goldman Sachs | Target Lowered | 10 → 9 | 7.61 |
| 2025-12-08 | Barclays | Update | — → 8.5 | 7.56 |
| 2025-10-30 | Stifel Nicolaus | Update | — → 8 | 8.82 |
